RecruitingPhase 4NCT06233617

Dexamethasone vs. Dexmedetomidine for ESPB in Pain Management After Spine Surgery


Sponsor

Poznan University of Medical Sciences

Enrollment

90 participants

Start Date

Mar 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Effect of perineurial dexamethasone and dexmedetomidine on erector spinal plane block duration for spine surgery.


Eligibility

Min Age: 18 YearsMax Age: 100 Years

Inclusion Criteria3

  • patients undergoing primary posterior lumbar decompression and stabilization with instrumentation involving multi-levels in the lumbar region,
  • aged \>18 years and \<100 years
  • ASA physical status 1, 2 or 3.

Exclusion Criteria5

  • refuse to participate,
  • history of opioid abuse,
  • infection of the puncture site,
  • aged \<18 years and \>100 years
  • ASA 4 and 5

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUG0.9% Sodium Chloride Injection

biliteral administration of 20ml of 0,2% ropivacaine + 2ml 0.9% sodium chloride for the erector spine plane block

DRUGDexamethasone 4 Mg/mL Injectable Solution

biliteral administration of 20ml of 0,2% ropivacaine with 4mg Dexamethasone for the erector spine plane block

DRUGDexmedetomidine injection

biliteral administration of 20ml of 0,2% ropivacaine with 50ug Dexmedetomidine for the erector spine plane block


Locations(1)

Poznan University of Medical Sciences

Poznan, Poznań, Poland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06233617


Related Trials